BIRC5, the gene encoding survivin, is upregulated in many human cancers68, and in the breast cancer PDXs and cell lines employed in our study, and has been shown to have low levels of expression in normal tissue types69,70, which makes survivin an appealing drug target. Here, BIRC5 is linked to breast cancer.